Home › Bloedkankers › Maryland › Baltimore
Bloedkankers klinische studies in Baltimore, MD
18 studies voor Bloedkankers zoeken deelnemers op locaties in en rond Baltimore (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruterenObservatieonderzoek
- UM Saint Joseph Medical Center, Towson · 8 mijl verwijderd
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruterenVroege fase 1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruterenFase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RekruterenFase 3
- MedStar Franklin Square Medical Center ( Site 0046), Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- en nog 2
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruterenFase 3
- Quetzal Site 23, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruterenFase 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
RekruterenVroege fase 1
- John Hopkins University, Baltimore
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
RekruterenFase 1
- Tania Jain, MD, Baltimore
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
RekruterenFase 2
- Johns Hopkins Hospital, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Johns Hopkins, Baltimore
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RekruterenFase 2
- University of Maryland, Baltimore, Baltimore
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekruterenObservatieonderzoek
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
RekruterenFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruterenFase 1
- Johns Hopkins School of Medicine, Baltimore
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Stoler Outpatient Cancer Center at the University of Maryland, Baltimore
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RekruterenObservatieonderzoek
- University of Maryland Medical Center, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruterenFase 1
- Johns Hopkins University, Baltimore
Bloedkankers studies in andere steden
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Columbus, OH13 studies
- Edison, NJ13 studies
- Nashville, TN13 studies
Andere studies in Baltimore
- Niet-kleincellige longkanker60 studies
- Borstkanker47 studies
- Prostaatkanker43 studies
- Longkanker40 studies
- Kanker (alle vormen)37 studies
- Aldermeesklierkanker31 studies
- Colorectale kanker31 studies
- Metastatische kanker28 studies
- Obesitas26 studies
- Blasenkanker24 studies
- Hartfalen24 studies
- Eierstokkanker22 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.